CD274 and melanoma: Inhibiting the PD-1/PD-L1 pathway plays a vital role in reinstating the immune system's natural function, which activates cytotoxic T-cells and enhances their infiltration into the tumor microenvironment, resulting in the regression of melanoma [35, 36].